LGALS1 and systemic lupus erythematosus: The present work suggests that altered glycosylation and, hence, the decreased binding of extracellular Gal-1 to SLE T cells can be another cause of the resistance to Gal-1-mediated immunomodulation, serving a putative novel pathogenic mechanism in SLE.